<DOC>
	<DOCNO>NCT02822118</DOCNO>
	<brief_summary>To evaluate efficacy safety TCM decoction Chang'an I Recipe treatment IBS-D. A multicenter , randomize , double-blind , placebo-controlled clinical trial design . Patients applied central random number give correspond treatment accord inclusion sequences.The treatment group administer Chang'an I Recipe , 150ml/bag , 3 times/day ; control group administer placebo , 150ml/bag , 3 times/day . Both course treatment 8 week .</brief_summary>
	<brief_title>Therapeutic Effect Chang'an I Recipe Irritable Bowel Syndrome With Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Patients meet diagnostic criterion Western medicine IBSD ; age 1870 year old ; baseline IBSSSS score 75 point ; voluntarily sign informed consent ; local resident could ensure followup , basic reading ability . Patients IBSC , M , uncertain form ; accompany serious lesion major organ include heart , liver , kidney , hematopoietic system disease , tumor ; gastrointestinal organic disease ( e.g. , chronic pancreatitis ) , systemic disease affect digestive tract motion ( e.g. , hyperthyroidism , diabetes , chronic renal insufficiency , nervous system disease ) ; undergo require constant use drug may affect gastrointestinal function ( e.g. , anticholinergic drug , calcium channel blocker , 5HT3 receptor antagonist , antidiarrheal agent , antacid , prokinetic agent , antidepressant , anxiolytic , intestinal flora regulate drug ) ; history abdominal surgery ( e.g. , cholecystectomy ) ; allergy history test drug severe allergy history food ; pregnant lactate female ; history neurological psychiatric disorder ; participate clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>IBS-D ; Chang'an I Recipe ; Placebo</keyword>
</DOC>